At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 319 enrolled
Drug / intervention
Dentifricesdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Efficacy Evaluation of Three Dentifrices Containing 35%, 20%, and 0% Sodium Bicarbonate on the Reduction of Plaque and Gingivitis
In Brief
A Phase 2 clinical trial evaluating Dentifrices for Gingival Inflammation and Bleeding and Dental Plaque. Completed, enrolled 319 participants across 1 site.
Detailed Summary
Clinical study to evaluate and compare the efficacy of two baking soda containing dentifrices, containing 20% and 35% baking soda, to a non-baking soda dentifrice for their ability to reduce gingivitis and plaque following 6-months of use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingival Inflammation and Bleeding, Dental Plaque
CountriesCanada
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
Enrollment StartFeb 2018
Primary CompletionAug 2018
First PostedJun 2019
TodayJul 2026
First PostedJun 17, 2019
Enrollment StartFeb 22, 2018
Primary CompletionAug 24, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.0 years ago
Interventions
Dentifricesdrug
Dentifrice on plaque, gingivitis, and bleeding.